260 related articles for article (PubMed ID: 29669917)
1. Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers.
Udugama M; Sanij E; Voon HPJ; Son J; Hii L; Henson JD; Chan FL; Chang FTM; Liu Y; Pearson RB; Kalitsis P; Mann JR; Collas P; Hannan RD; Wong LH
Proc Natl Acad Sci U S A; 2018 May; 115(18):4737-4742. PubMed ID: 29669917
[TBL] [Abstract][Full Text] [Related]
2. Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres.
Voon HPJ; Collas P; Wong LH
Trends Cancer; 2016 Mar; 2(3):114-116. PubMed ID: 28741530
[TBL] [Abstract][Full Text] [Related]
3. ATRX and DAXX: Mechanisms and Mutations.
Dyer MA; Qadeer ZA; Valle-Garcia D; Bernstein E
Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 28062559
[TBL] [Abstract][Full Text] [Related]
4. Arabidopsis ATRX Modulates H3.3 Occupancy and Fine-Tunes Gene Expression.
Duc C; Benoit M; Détourné G; Simon L; Poulet A; Jung M; Veluchamy A; Latrasse D; Le Goff S; Cotterell S; Tatout C; Benhamed M; Probst AV
Plant Cell; 2017 Jul; 29(7):1773-1793. PubMed ID: 28684426
[TBL] [Abstract][Full Text] [Related]
5. Hypo-methylation mediates chromosomal instability in pancreatic NET.
Marinoni I; Wiederkeher A; Wiedmer T; Pantasis S; Di Domenico A; Frank R; Vassella E; Schmitt A; Perren A
Endocr Relat Cancer; 2017 Mar; 24(3):137-146. PubMed ID: 28115389
[TBL] [Abstract][Full Text] [Related]
6. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM
Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196
[TBL] [Abstract][Full Text] [Related]
7. [The epigenetic regulation of ribosomal DNA and tumorigenesis].
Cheng XR; Hu XL; Jiang Q; Huang XW; Wang N; Lei L
Yi Chuan; 2019 Mar; 41(3):185-192. PubMed ID: 30872255
[TBL] [Abstract][Full Text] [Related]
8. The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin.
Truch J; Downes DJ; Scott C; Gür ER; Telenius JM; Repapi E; Schwessinger R; Gosden M; Brown JM; Taylor S; Cheong PL; Hughes JR; Higgs DR; Gibbons RJ
Nat Commun; 2022 Jun; 13(1):3485. PubMed ID: 35710802
[TBL] [Abstract][Full Text] [Related]
9. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
10. ATRX/DAXX: Guarding the Genome against the Hazards of ALT.
Clatterbuck Soper SF; Meltzer PS
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107548
[TBL] [Abstract][Full Text] [Related]
11. Combined inhibition of RNA polymerase I and mTORC1/2 synergize to combat oral squamous cell carcinoma.
Shi S; Luo H; Wang L; Li H; Liang Y; Xia J; Wang Z; Cheng B; Huang L; Liao G; Xu B
Biomed Pharmacother; 2021 Jan; 133():110906. PubMed ID: 33190037
[TBL] [Abstract][Full Text] [Related]
12. Global changes in chromatin accessibility and transcription following ATRX inactivation in human cancer cells.
Liang J; Liu H; Li G; Qian J; Gao R; Zhou Y; Wang X
FEBS Lett; 2020 Jan; 594(1):67-78. PubMed ID: 31329278
[TBL] [Abstract][Full Text] [Related]
13. Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
Kim JY; Brosnan-Cashman JA; An S; Kim SJ; Song KB; Kim MS; Kim MJ; Hwang DW; Meeker AK; Yu E; Kim SC; Hruban RH; Heaphy CM; Hong SM
Clin Cancer Res; 2017 Mar; 23(6):1598-1606. PubMed ID: 27663587
[No Abstract] [Full Text] [Related]
14. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
Hackeng WM; Brosens LAA; Kim JY; O'Sullivan R; Sung YN; Liu TC; Cao D; Heayn M; Brosnan-Cashman J; An S; Morsink FHM; Heidsma CM; Valk GD; Vriens MR; Nieveen van Dijkum E; Offerhaus GJA; Dreijerink KMA; Zeh H; Zureikat AH; Hogg M; Lee K; Geller D; Marsh JW; Paniccia A; Ongchin M; Pingpank JF; Bahary N; Aijazi M; Brand R; Chennat J; Das R; Fasanella KE; Khalid A; McGrath K; Sarkaria S; Singh H; Slivka A; Nalesnik M; Han X; Nikiforova MN; Lawlor RT; Mafficini A; Rusev B; Corbo V; Luchini C; Bersani S; Pea A; Cingarlini S; Landoni L; Salvia R; Milione M; Milella M; Scarpa A; Hong SM; Heaphy CM; Singhi AD
Gut; 2022 May; 71(5):961-973. PubMed ID: 33849943
[TBL] [Abstract][Full Text] [Related]
15. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM
Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196
[TBL] [Abstract][Full Text] [Related]
16. Induction of the alternative lengthening of telomeres pathway by trapping of proteins on DNA.
Rose AM; Goncalves T; Cunniffe S; Geiller HEB; Kent T; Shepherd S; Ratnaweera M; O'Sullivan RJ; Gibbons RJ; Clynes D
Nucleic Acids Res; 2023 Jul; 51(13):6509-6527. PubMed ID: 36940725
[TBL] [Abstract][Full Text] [Related]
17. The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats.
Nguyen DT; Voon HPJ; Xella B; Scott C; Clynes D; Babbs C; Ayyub H; Kerry J; Sharpe JA; Sloane-Stanley JA; Butler S; Fisher CA; Gray NE; Jenuwein T; Higgs DR; Gibbons RJ
EMBO Rep; 2017 Jun; 18(6):914-928. PubMed ID: 28487353
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel gene fusion in ALT positive osteosarcoma.
Mason-Osann E; Dai A; Floro J; Lock YJ; Reiss M; Gali H; Matschulat A; Labadorf A; Flynn RL
Oncotarget; 2018 Aug; 9(67):32868-32880. PubMed ID: 30214690
[TBL] [Abstract][Full Text] [Related]
19. ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress.
Teng YC; Sundaresan A; O'Hara R; Gant VU; Li M; Martire S; Warshaw JN; Basu A; Banaszynski LA
Nat Commun; 2021 Jun; 12(1):3887. PubMed ID: 34162889
[TBL] [Abstract][Full Text] [Related]
20. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma.
Wang Y; Yang J; Wild AT; Wu WH; Shah R; Danussi C; Riggins GJ; Kannan K; Sulman EP; Chan TA; Huse JT
Nat Commun; 2019 Feb; 10(1):943. PubMed ID: 30808951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
